Drug Name: | Calcitriol (32222-06-3) |
---|---|
PubChem ID: | 5280453 |
SMILES: | C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCC/C2=CC=C/3C[C@H](C[C@@H](C3=C)O)O)C |
InchiKey: | GMRQFYUYWCNGIN-NKMMMXOESA-N |
Therapeutic Category: | Bone Density Conservation Agents, Calcium Channel Agonists, Cardiovascular Agents, Growth Substances, Membrane Transport Modulators, Micronutrients, Vasoconstrictor Agents, Vitamins |
Molecular Weight (dalton) | : | 416.646 |
LogP | : | 5.7047 |
Ring Count | : | 0 |
Hydrogen Bond Acceptor Count | : | 3 |
Hydrogen Bond Donor Count | : | 3 |
Total Polar Surface Area | : | 60.69 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|---|---|---|
Acute Effects | Osteocalcin (P02818) | Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man. [ ADR Type 1 ] | Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man |
Acute Effects | Parathyroid hormone (Q03431) | Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone@ osteocalcin and calcitriol in man [ ADR Type 1 ] | Acute effects of intravenous 1 alpha-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man |
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category